
Editor @physicianswkly @_formedics, NJ dweller, Iowa native, mother of 3, sister of 8, logophile, baker, Broadway musical fanatic, and yacht rock aficionado.
Sparta, NJ
Joined October 2013
- Tweets655
- Following729
- Followers159
- Likes497
Teresa Leisen Sellinger retweeted
💵 RVUs still matter. They just don’t tell the whole story anymore.
Tynan Kugler, MBA, MPH (@TOKugler @PYAHealthcare) explains why healthcare organizations are moving beyond simple RVU-based #compensation formulas and paying for access, quality, continuity, and the invisible work that keeps modern medicine functioning.
Read & learn👉🏻 bit.ly/4z9c85f
#MedX #MedTwitter
Teresa Leisen Sellinger retweeted
⚕️Why are physicians winning so many #NoSurprisesAct arbitration disputes—and why aren't insurers paying up?
In our latest Q&A, ASA President Dr. Jeffrey T. Mueller (@ASALifeline @MayoClinic) explains how commercial payers' refusal to pay binding IDR awards—and making $1 offers for services like MRIs—erodes the entire foundation of in-network contracting.
Get the full breakdown👉🏻 bit.ly/4iRNal2
#MedX
Teresa Leisen Sellinger retweeted
🥼 #Obesity stigma doesn’t just damage trust; It changes care.
In this roundtable, Alex McDonald, MD (@AlexMMTri); Regina Ragasa, DO; Shyam Sundaresh, MD; Anthony Auriemma, MD, JD (@CenterHN); & Frank Domino, MD, discuss how person‑first language, respectful communication, and supportive clinical environments can transform outcomes for patients with #overweight.
Watch now👉🏻 bit.ly/4zeJb85
@PermanenteDocs #MedX

ALT A group of five medical professionals are featured in a promotional image for a roundtable video titled "Creating Accessible & Supportive Spaces for Patients With Obesity." Their names are Alex McDonald, MD; Regina Ragasa, DO; Shyam Sundarsh, MD; Anthony Auriemma, MD, JD; Frank Domino, MD. The background is a gradient of light blue. The Professional Association's logo is in the top right corner.
Teresa Leisen Sellinger retweeted
Check out Dr. Sommer Gunia’s thoughtful conversation about intraoperative margin assessment in breast-conserving surgery in this @physicianswkly article.
physiciansweekly.com/post/qa…
@tesellinger
📌Adjunc. tool; not replacement for histopath/diagnosis.
Teresa Leisen Sellinger retweeted
🩻 The first neurologic exam isn’t the final chapter.
Dr. Jonathan Yun (@nyulangone) shares a dramatic recovery after severe cervical #SCI and outlines what clinicians should know about prognostication, early intervention & sustaining long‑term patient engagement in recovery.
🎧Tune in▶️ bit.ly/4BRzM8Z
#NeuroX
Teresa Leisen Sellinger retweeted
🤰🏻"Cosmetic procedures are increasingly accessible, but pregnancy-specific safety evidence remains limited," says Dr. Kanwal (@MyHealthTeam)
In this Q&A, she explains why “not proven safe” and “known to be harmful” are not the same thing, and why that distinction matters for #dermatologists counseling patients.
Dive in👉 bit.ly/4AsE8Sx
#DermX #OBGYNX
Teresa Leisen Sellinger retweeted
🫷 Too many vulnerable patients with #NSCLC are excluded from the trials that define standard care.
Dr. Claudia Parisi (@PARISImd @GustaveRoussy) discusses how age, #frailty, comorbidities & status complicate treatment decisions, & why precision oncology must extend beyond #TumorBiology to the patient sitting in front of us.
Don't miss this Q&A👉 bit.ly/3WzuI9e
#OncX #LungCancer
Teresa Leisen Sellinger retweeted
💉A new #mRNA flu vaccine. A #measles resurgence. Endless misinformation. Welcome to #vaccine season.
Dr. Parodi (@StephenParodiMD @PermanenteDocs) explains why evidence alone won’t move patients & how physicians can rebuild their trust & confidence.
👉️buff.ly/ifm5YB4
Teresa Leisen Sellinger retweeted
🛌The farther financial authority sits from the bedside, the easier patients become metrics
Dr. Kahn (@dr_kahn78) shares how readmission targets, transfer reviews & investor expectations shape clinical decisions before patients reach the hospital👉buff.ly/aTEfses
#MedX
Teresa Leisen Sellinger retweeted
💉 Experimental #peptides are one White House policy shift away from broader access, despite limited clinical evidence and no #FDA approval for many of the claims being made.
Amy Maxmen (@KFFHealthNews) separates fact from hype
here👉 buff.ly/o2Ag9QY
#MedX #MedTwitter
Teresa Leisen Sellinger retweeted
🎃Forget #Frankenstein. The most terrifying doctors in history were real.
From murderous physicians to medical monsters who violated ethics, this #Halloween slideshow explores 14 of medicine’s darkest figures. Check it out... if you dare.
👉buff.ly/8n9zcYY
Teresa Leisen Sellinger retweeted
🧛 Need a dose of Halloween humor?
Check out this week's cartoon featuring a patient whose baseline treatment plan already includes strict UV avoidance, then head to our cartoon section for more medical mirth.
Get your giggle on👉 buff.ly/jhcbby0
#MedicalCartoon #MedX
Teresa Leisen Sellinger retweeted
🏳️🌈 Risk‑based STI screening in #PrEP care sounds efficient, but is it missing infections?
Dr. Katherine Meyers (@ColumbiaMed) & team's study laid out the evidence behind universal vs risk‑based #STI screening in PrEP care.
Catch the visual summary👉buff.ly/jbuhPWe
#HIV
Teresa Leisen Sellinger retweeted
👩⚖️What you think is hearsay might still make it into court.
Dr. MedLaw breaks down the exceptions that can flip a #MedicalMalpractice trial—and why every clinician should understand them before taking the stand.
🎧️Tune in now
👉️buff.ly/eMyC9YA
#MedTwitter #MedLaw
Teresa Leisen Sellinger retweeted
💻️If 1/3 of patients rely on Google during flares, continuity isn’t working.
Dr. Kanwal (@MyHealthTeam) shares how culturally competent care, clear flare plans & screening for barriers can finally make #psoriasis care equitable.
Q&A👉️buff.ly/DZJx6ip
Teresa Leisen Sellinger retweeted
🦠 #Oseltamivir’s impact is real but modest & timing is everything.
Dr. Brodkey (@frankbrodkey @uw_medicine) cuts through decades of mixed data to clarify what the drug actually does for #influenza & where clinicians must still tread carefully
👉️buff.ly/rNEFuen
#MedX
Teresa Leisen Sellinger retweeted
👵A + #amyloid test isn’t a treatment plan—esp. for older adults w/ multimorbidity.
Dr. Stefanacci (@Inspira__Health @JeffersonUniv @RowanUniversity) explains what these assays can tell you, why performance varies & how to avoid misleading families👉️buff.ly/RoU1cN0
Teresa Leisen Sellinger retweeted
♀️ There’s no screening test for #EndometrialCancer, just symptom recognition.
Dr. Nichols (@HazelBNichols @UNC) & Ms. Brookes (@UNC) found that 90% of survivors reported bleeding symptoms, yet only 1 in 4 knew it could signal cancer.
Q&A👉️buff.ly/yMVc2cv
#MedTwitter
Teresa Leisen Sellinger retweeted
📏If we’re treating #EDDs w/out tracking growth by genotype, we’re missing the clinical plot.
Keith Choate, MD, PhD (@ChoateMD @YaleMed) et al showed how early‑life deficits diverge sharply across variants & why precision #dermatology must start early👉️buff.ly/dLAOBwK
Teresa Leisen Sellinger retweeted
🫘Patients choosing #CKM are choosing dignity
Michelle Prong Geiger, MD (@ThompsonCareers) & team explained the motivations, caregiver tensions & nephrology blind spots that make CKM a clinically sound yet poorly supported pathway in #ESKD
👉️buff.ly/rSgRVLk
#MedTwitter



















